HanX's Platform

Clinical validated PD1 mAb + CD47 or ILs

“Cold”

tumor

Immunologic

Conversion

“Hot”

tumor

Precision Tumor Targeting Antibody Platform

Bs-mAb

Spacer

+

2    Tumor Targeting

nb

mAb

BsAb

mAb

GPSmAb